Consumer group says drugmakers abuse U.S. patent system to keep prices high
Gaming of U.S. Patent System Is Keeping Drug Prices Sky High
Save America’s Patent System
Addressing Drug Patent Abuse: Restoring The Role Of Inter Partes Review
An Entrepreneur’s Quest To Fix Drug Patents And Save Lives
Ford School hosts conversation on drug patent system reform
Ten years ago, I testified before Congress about drug pricing — and it’s only gotten worse. Here’s what’s wrong, and how we may be able to fix it.
Senate Targets Hoarding of Drug Patents to Deter Competition
Report Finds 89% of Total U.S. Patent Applications on Humira Were Filed After FDA Approval – Pointing to a Deliberate Strategy to Delay Competition
I-MAK Welcomes Two New Board Members to Champion the Access to Medicines Movement